Genentech, UPenn End Herceptin Patent Row On Eve Of Trial
Genentech Inc. dropped its declaratory suit against the University of Pennsylvania on Friday, saying the parties had settled their patent infringement dispute related to the drug company's breast cancer treatment Herceptin...To view the full article, register now.
Already a subscriber? Click here to view full article